(±)Cyanopindolol hemifumarate (CAS 69906-85-0)

Cyanopindolol hemifumarate is a beta-adrenergic antagonist that functions by competitively inhibiting the binding of catecholamines to beta-adrenergic receptors in cells. (±)Cyanopindolol Hemifumarate′s mechanism of action involves blocking the activation of beta-adrenergic receptors, which are G protein-coupled receptors found on the surface of many cell types. By doing so, it interferes with the downstream signaling pathways that are typically activated by catecholamines, ultimately leading to a reduction in the cellular response to sympathetic nervous system stimulation. (±)Cyanopindolol Hemifumarate′s functional role in development applications lies in its ability to selectively modulate beta-adrenergic receptor activity, allowing for the investigation of the specific cellular and molecular processes influenced by these receptors. Its competitive binding to beta-adrenergic receptors may be a useful for studying the physiological and pathological roles of these receptors in various experimental models.